Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

BioDelivery Sciences to Receive $10M from Endo Pharmaceuticals

February 23, 2015 10:56 am | News | Comments

BioDelivery Sciences International, Inc. and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for Belbuca. Read more..


Improving Patient Onboarding with Advancements in Medical Device Training

February 23, 2015 10:48 am | by Craig Baker, Executive Vice President, Noble | Articles | Comments

For some patients diagnosed with chronic medical conditions, weekly or biweekly self-administration using drug delivery devices is often a necessary component of a successful treatment program. Read more...


The Next Generation of Antibiotics Might Be Right Under Our Feet

February 23, 2015 10:21 am | News | Comments

The discovery of a new antibiotic called teixobactin was announced by international team of researchers, in January this year. It is the most significant new antibiotic to be discovered in more than 30 years, and it may help combat the growing number of drug-resistant bacteria. Read more...


Asthma Drug Improves Lung Function: Phase 3 Data

February 23, 2015 10:13 am | News | Comments

Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat inhaler from five Phase 3 trials from the UniTinA-asthma program at the 2015 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Houston, Texas. Read more..


Oral Med Shows Promise in Hormone-Resistant Breast Cancer

February 23, 2015 10:03 am | News | Comments

​Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments. Read more...


Anti-Vaccine Mothers Discuss Their Thinking Amid Backlash

February 23, 2015 9:57 am | by Gosia Wozniacka, Associated Press | News | Comments

One is a businesswoman and an MBA graduate. Another is a corporate vice president. The third is a registered nurse. Read more...

Burkina Faso: Food Aid Shortage Threatens HIV Patients

February 23, 2015 9:51 am | by Brahima Ouedraogo, Associated Press | News | Comments

Thousands of people living with HIV/AIDS in Burkina Faso could soon face cuts in food assistance because of a funding shortage. Read more...                    


Garden Hose a Breeding Ground for Legionnaire's Disease

February 23, 2015 9:32 am | by University of New South Wales | News | Comments

It is synonymous with an Aussie summer but the humble backyard hose could be a bacterial breeding ground, providing the ideal conditions for the organisms that cause Legionnaires’ disease to flourish. Read more...        


Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Hepatitis C Medication in India

February 23, 2015 9:24 am | News | Comments

The drugs, Harvoni and Solvadi, are expected to arrive in the second quarter of 2015. Read more...                           


Fearing Ebola, North Korea Bars Tourists from Capital Marathon

February 23, 2015 8:56 am | by Eric Talmadge, Associated Press | News | Comments

North Korea barred foreigners from one of its most popular tourist events - the annual Pyongyang marathon - because of concerns over the Ebola virus. Read more...                


Valeant Agrees to Buy Salix for About $10 Billion in Cash

February 23, 2015 8:48 am | by Alex Veiga, AP Business Writer | News | Comments

Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. Read more...                  


Safety, Life-Saving Efficacy of Statins Exaggerated: USF Scientist

February 20, 2015 1:08 pm | News | Comments

Hailed as miracle drugs when they hit the market two decades ago, statins, the cholesterol-lowering drugs prescribed to prevent heart attacks, are not as effective nor as safe as we have been led to believe, say Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida. Read more..


Lawyer: Teen Infected by 'Superbug' Struggling to Survive

February 20, 2015 12:31 pm | by Alicia Chang and John Rogers, AP Science Writer - Associated Press | News | Comments

An 18-year-old student is struggling to survive after he was infected by a "superbug" outbreak tied to contaminated medical instruments at a Los Angeles hospital, his attorney said. Read more...

Lilly Provides Update on Evacetrapib Phase 3 Trial

February 20, 2015 12:25 pm | News | Comments

Eli Lilly and Company has accepted the recommendation of the ACCELERATE study academic executive committee, based on emerging science in the cardiovascular field, to extend the Phase 3 trial of the investigational medicine evacetrapib by approximately six months. Read more....


Building Understanding of Hepatitis C Virus Replication

February 20, 2015 12:17 pm | News | Comments

The study, published online in the journal Cell Host & Microbe, explains the role of one small, but critical molecule called miR-122 in helping the virus replicate itself. Read more...                           


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.